JAGUAR HEALTH, INC. Interest Payable
JAGUAR HEALTH, INC. (JAGX) had Interest Payable of $15.49 thousand as of 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2018-05-15
- 2018-03-31: Interest Payable $15.49K.
- 2017-09-30: Interest Payable $47.39K.
- 2017-06-30: Interest Payable $42.85K.
- 2017-03-31: Interest Payable $38.37K.
| Period end | Interest Payable |
|---|---|
| 2018-03-31 | $15.49K 10-Q · filed 2018-05-15 |
| 2017-09-30 | $47.39K 10-Q · filed 2017-11-20 |
| 2017-06-30 | $42.85K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $38.37K 10-Q/A · filed 2017-06-23 |
| 2016-12-31 | $33.93K 10-Q · filed 2017-11-20 |
| 2015-12-31 | $15.88K 10-K · filed 2017-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |